Douglas W. Pagan, Chief Financial Officer at Paratek Pharmaceuticals, Inc. (PRTK), sold 4,595 shares at $25.00 ($115K) on 2017-06-19, disclosed to the SEC on 2017-06-21.
Open-market sale of $115k PRTK by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PRTK | SELL | 2018-10-16 | $25K | — | Filing → |
| PRTK | SELL | 2018-10-04 | $149K | — | Filing → |
| PRTK | SELL | 2018-04-10 | $133K | — | Filing → |